The survey was conducted April 27-30 by Premier, a group purchasing organization.
Eighty-seven percent of the respondents said their facilities intend to test any patient admitted for an elective procedure for COVID-19, but only 27 percent said they were currently able to do so.
According to the survey, hospitals and healthcare facilities need to expand their current COVID-19 diagnostic testing capacity by at least 211 percent to even partially resume elective procedures and diagnostic services.
Of the respondents, 81 percent said they intend to screen all employees for symptoms of COVID-19 before resuming nonemergency procedures, but only 32 percent said they’d be able to give COVID-19 diagnostic tests to all of their front-line healthcare workers. Only 22 percent said they’re able to test all employees, including food service workers and janitors.
The survey indicates that shortages of reagents and testing swabs are the main barriers to more widespread testing.
Read the full survey here.
More articles on supply chain:
ICE working with Amazon, Pfizer to keep fake COVID-19 supplies out of US
FDA tightens standards for COVID-19 antibody tests
LabCorp furloughs employees
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
